Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Qual Life Res. 2017 Dec 8;27(3):811–822. doi: 10.1007/s11136-017-1755-6

Table 3.

Correlations among cognition measured by using different methods and depression

Responses analyzed together for all three HD groups
EF GC Self-rated Composite PROMIS Depression Objective Composite Clinician- Rated Composite
Neuro-QoL Executive Function (EF) -- .739** .735** −.410** .513** .418**
Neuro-QoL General Concerns (GC) -- .671** −.493** .360** .342**
Self-rated Composite -- −.408** .522** .376**
PROMIS Depression -- −.163** −.168**
Objective Composite -- .388**
Clinician-Rated Composite --
Responses analyzed together for all three HD groups controlling for depression
EF GC Self-rated Composite Objective Composite Clinician-Rated Composite
Neuro-QoL Executive Function (EF) -- .676** .682** .495** .388**
Neuro-QoL General Concerns (GC) -- .591** .325** .302**
Self-rated Composite -- .506** .342**
Objective Composite -- .371**
Clinician-Rated Composite --
Responses by HD disease-stage
Prodromal Early-Stage Late-Stage
EF GC Self Dep Obj Clin EF GC Self Dep Obj Clin EF GC Self Dep Obj Clin
EF -- .790** .704** −.502** .187* .483** -- .764** .599** −.471** .199** .233** -- .492** .634** −.301** .150 .069
GC -- .654** −.474** .143 .421** -- .655** −.517** .193** .264** -- .610** −.482** −.007 .040
Self -- −.483** .166* .401** -- −.469** .275** .235** -- −.350** .202 .099
Dep -- -.080 −.259** -- −.158* .071 -- .036 −.053
Obj -- .233** -- .008 -- .232
Clin -- -- --

Note. HD = Huntington disease; EF: Neuro-QoL Executive Function; GC: Neuro-QoL General Concerns; Self: Self-rated composite; Dep: PROMIS Depression; Obj: Objective composite; Clin: Clinician-rated composite.

**

p<0.01